Evidence map›Paper›PMID 30429370›Full record

ArticleJCI insight2018

Early expansion of donor-specific Tregs in tolerant kidney transplant recipients.

Thomas M Savage, Brittany A Shonts, Aleksandar Obradovic, Susan Dewolf, Saiping Lau, Julien Zuber, Michael T Simpson, Erik Berglund, Jianing Fu, Suxiao Yang and 5 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Preclinical and clinical studies on kidney allograft tolerance via hematopoietic chimerism.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The 2025 Nobel Prize in Physiology or Medicine Honors the Immune Peacekeepers.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. T cell plasticity in renal autoimmune disease.Cell and tissue research · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Thomas M SavageColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Brittany A ShontsColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Aleksandar ObradovicColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Susan DewolfColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Saiping LauColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Julien ZuberColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Michael T SimpsonColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Erik BerglundColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Jianing FuColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Suxiao YangColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Siu-Hong HoColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Qizhi TangDepartment of Surgery, University of California San Francisco, San Francisco, California, USA.
Laurence A TurkaCenter for Translational Sciences, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Yufeng ShenCenter for Computational Biology and Bioinformatics, Department of Systems Biology, Columbia University, New York, New York, USA.
Megan SykesColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
Columbia University Irving Medical Center · USColumbia University · USMassachusetts General Hospital · USUniversity of California, San Francisco · US

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
Translational Biomarker Analytical Core (TBAC)P30DK063608 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DOMENICO ACCILI · 2003 to 2026
$36.7M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007367 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI REINER, STEVEN L · 1985 to 2021
$25.1M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
NCI NIH HHS P30 CA013696NCRR NIH HHS S10 RR027050NIAID NIH HHS UM1 AI109565NIDDK NIH HHS P30 DK063608NIGMS NIH HHS T32 GM007367NIH HHS S10 OD020056
6 · The paper itself

Abstract

Allograft tolerance, in which a graft is accepted without long-term immunosuppression, could overcome numerous obstacles in transplantation. Human allograft tolerance has been intentionally induced across HLA barriers via combined kidney and bone marrow transplantation (CKBMT) with a regimen that induces only transient chimerism. Tregs are enriched early after CKBMT. While deletional tolerance contributes to long-term tolerance, the role of Tregs remains unclear. We have optimized a method for identifying the donor-specific Treg repertoire and used it to interrogate the fate of donor-specific Tregs after CKBMT. We expanded Tregs with several different protocols. Using functional analyses and T cell receptor sequencing, we found that expanding sorted Tregs with activated donor B cells identified the broadest Treg repertoire with the greatest potency and donor specificity of suppression. This method outperformed both alloantigen stimulation with CTLA4Ig and sequencing of CFSElo cells from the primary mixed lymphocyte reaction. In 3 tolerant and 1 nontolerant CKBMT recipients, we sequenced donor-specific Tregs before transplant and tracked them after transplant. Preexisting donor-specific Tregs were expanded at 6 months after CKBMT in tolerant patients and were reduced in the nontolerant patient. These results suggest that early expansion of donor-specific Tregs is involved in tolerance induction following CKBMT.

Indexed as

Kidney TransplantationTransplantation ToleranceB-LymphocytesBone Marrow TransplantationCD4 Lymphocyte CountCTLA-4 AntigenHumansLymphocyte Culture Test, MixedReceptors, Antigen, T-CellTissue DonorsT-Lymphocytes, RegulatoryCTLA-4 AntigenCTLA4 protein, humanReceptors, Antigen, T-CellImmunologyOrgan transplantationT-cell receptorToleranceTransplantation

Identifiers

PMID30429370
PMCPMC6302945
OpenAlexW2901899891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.